探索酸水平对患者治疗饮食的影响:一项观察性研究
Stacey Tarrant1, Aurelija Liubauske1, Guangyu Zhu2
1Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Epilepsia open
|February 28, 2025
概括
对于接受饮食 (KD) 和酸 (VPA) 的患者,较高的VPA水平与较低的血 (BHB) 水平相关. 监测VPA和BHB对于有效控制发作至关重要.
科学领域:
- 神经学 神经学
- 儿科 儿科 儿科
- 临床营养学 临床营养学
背景情况:
- 性饮食 (KD) 是一种被公认的治疗儿童耐火性的疗法.
- 同时使用KD和酸 (VPA) 可能会影响VPA的血液水平.
- 在儿科患者中,VPA和水平之间的相互作用需要进一步研究.
研究的目的:
- 在接受两种疗法治疗的儿童中,研究烯酸 (VPA) 水平和β-基酸盐 (BHB) 水平之间的关系.
- 为了确定VPA如何影响BHB度在患有耐火性的儿科患者.
主要方法:
- 对36名儿科患者 (<18岁) 进行了回顾性分析,他们接受了VPA和经典KD (2018-2022) 的治疗.
- 收集的数据包括VPA和BHB水平,剂量,KD比率和患者人口统计数据.
- 使用单变量和多变量线性混合效应回归模型来评估VPA和BHB水平之间的关联.
主要成果:
- 在VPA和BHB水平之间发现了统计学上显著的负相关性.
- 每增加1mmol/L的BHB与6.39μg/mL的VPA水平下降有关 (p < 0.001).
- 这表明了一个反向关系:较高的VPA水平与较低的BHB水平有关,反之亦然.
结论:
- 建议在接受KD和VPA同时治疗的儿科患者中密切监测VPA和BHB水平.
- 根据观察到的VPA和BHB水平,治疗计划可能需要调整以优化控制.
- 了解这种药理动力学相互作用对于在这种患者群体中有效管理至关重要.
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
306
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
306
01:20Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
01:17Antiepileptic Drugs: Calcium Channel Blockers
290
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
290
01:08Antiepileptic Drugs: Sodium Channel Blockers
340
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
340
01:24Arteries of the Lower Limbs
176
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
176